Statistics
Publications
11
Citations
3.9K
H-Index
11
Active since
2004
Affiliations
Heidi M. Ott is an author at GlaxoSmithKline (United States) specializing in oncology, medicine, and molecular oncology.
Publications per year
2004–2017
11
11
EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2-activating mutations
Michael T. McCabe, Heidi M. Ott, Gopinath Ganji et al. · Nature · 2012 · 1.8K citations
Michael T. McCabe, Alan P. Graves, Gopinath Ganji et al. · Proceedings of the National Academy of Sciences · 2012 · 485 citations · Full text
Life Sciences, Genetics, Oncology +17
1–5 of 11